MOVIN Program for Early Mobility in Aging Adults

Recruiting at 2 trial locations

Overseen By Linsey M Steege, PhD

Age: 65+

Sex: Any

Trial Phase: Academic

Sponsor: University of Wisconsin, Madison

Disqualifiers: Power of attorney, Amputation, Hospice, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

387 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on increasing mobility, so it's best to ask the study team for guidance.

What data supports the effectiveness of the MOVIN treatment for early mobility in aging adults?

The research suggests that early mobility programs, like MOVIN, can improve mobility and clinical outcomes in older adults, as seen in studies on similar mobility-focused interventions and protocols. ^{1 2 3 4 5}

How does the MOVIN treatment for early mobility in aging adults differ from other treatments?

The MOVIN program is unique because it focuses on early mobility in aging adults, potentially incorporating elements like physical activity counseling and environmental modifications to enhance mobility, unlike standard treatments that may not address these comprehensive factors. ^{6 7 8 9 10}

What is the purpose of this trial?

The MOVIN (Mobilizing Older adult patients Via a systems-based Intervention) randomized controlled trial is designed to evaluate the impact of the MOVIN intervention on improving the functional ability of older adult hospital patients and reducing their healthcare utilization post-hospitalization. MOVIN is a program to increase patient ambulation while hospitalized. The study's hypothesis is that MOVIN will improve functional outcomes for hospitalized older adult patients by producing a change in nursing practice and culture of ambulation on inpatient units. MOVIN is a unit-based intervention. Therefore all patients on this unit are exposed to the intervention once it is implemented regardless of whether or not they participate in the trial. The study will enroll 360-420 total hospitalized participants 65 years and older for the duration of their stay.

Research Team

Linsey M Steege, PhD

Principal Investigator

University of Wisconsin, Madison

Eligibility Criteria

This trial is for older adults aged 65 or above who were living at home before hospital admission, can walk (with help if needed), and have a doctor's order to walk. They must be in the hospital's general medical unit and speak English. People with bed rest orders, severe cognitive issues like dementia, wheelchair users, amputees, or those receiving end-of-life care cannot join.

Inclusion Criteria

I am 65 years old or older.

able to speak and understand English

admitted to hospital's general adult medical unit

Exclusion Criteria

You have a medical condition that cannot be cured and require palliative care.

You are currently receiving hospice care.

I have had an amputation of part of my leg.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Pre-intervention

Recruitment of older adult patients on units across hospitals before the implementation of the MOVIN intervention

6-8 months

Intervention

Implementation of the MOVIN intervention to improve patient ambulation and change nursing practice

14 weeks

Post-intervention

Follow-up and data collection on patient outcomes and healthcare utilization post-MOVIN implementation

6 months

Follow-up

Participants are monitored for functional ability and healthcare utilization at discharge, and 1, 3, and 6 months post-discharge

7 months

Treatment Details

Interventions

• MOVIN

Trial Overview The MOVIN program aims to get older adult patients walking more during their hospital stay to improve their mobility and reduce healthcare needs after leaving the hospital. It changes how nurses encourage walking. All patients on certain units will experience MOVIN once it starts.

Participant Groups

Group I: Post-intervention Experimental Treatment 1 Intervention

160-200 older adult patients (age 65 or older) will be recruited on four units across two hospitals (two units per hospital) over 6-8 months after MOVIN has been implemented on the unit.

Group II: Nurses Experimental Treatment 1 Intervention

Nurses will complete surveys and provide qualitative data to assess barriers to implementation

Group III: Pre-intervention/control Active Control 1 Intervention

160-200 older adult patients (age 65 or older) will be recruited on four units across two hospitals (two units per hospital) over 6-8 months prior to implementation of the unit-based MOVIN intervention.

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials

1,249

Recruited

3,255,000+

Wake Forest University Health Sciences

Collaborator

Trials

1,432

Recruited

2,506,000+

Aurora Health Care

Collaborator

Trials

46

Recruited

16,400+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials

415

Recruited

6,777,000+

Findings from Research

A 12-month multifactorial intervention significantly improved mobility-related disability in 241 frail older adults, as evidenced by better scores on the Goal Attainment Scale and Life Space Assessment compared to the control group.

Participants in the intervention group also demonstrated a slight increase in walking speed and higher scores on activity measures, indicating enhanced mobility and participation in daily life activities.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effect of a multifactorial interdisciplinary intervention on mobility-related disability in frail older people: randomised controlled trial. Fairhall, N., Sherrington, C., Kurrle, SE., et al.[2022]

References

1. United States pubmed.ncbi.nlm.nih.gov

Which impairments are most associated with high mobility performance in older adults? Implications for a rehabilitation prescription. [2008]

2. United States pubmed.ncbi.nlm.nih.gov

Mobility-related function in older adults: assessment with a 6-minute walk test. [2022]

3. Netherlands pubmed.ncbi.nlm.nih.gov

Sustainability of a nurse-driven early progressive mobility protocol and patient clinical and psychological health outcomes in a neurological intensive care unit. [2018]

4. England pubmed.ncbi.nlm.nih.gov

Managing mobility outcomes in vulnerable seniors ( MMOVeS): a randomized controlled pilot study. [2018]

5. United States pubmed.ncbi.nlm.nih.gov

Impaired Mobility and Functional Decline in Older Adults: Evidence to Facilitate a Practice Change. [2018]

6. England pubmed.ncbi.nlm.nih.gov

Development and feasibility of an automated call monitoring intervention for older wheelchair users: the MOvIT project. [2018]

7. England pubmed.ncbi.nlm.nih.gov

Effect of a multifactorial interdisciplinary intervention on mobility-related disability in frail older people: randomised controlled trial. [2022]

8. United States pubmed.ncbi.nlm.nih.gov

Randomized controlled trial protocol feasibility: The Wheelchair Self-Efficacy Enhanced for Use (WheelSeeU). [2019]

9. Korea (South) pubmed.ncbi.nlm.nih.gov

Promoting mobility in older people. [2021]

10. England pubmed.ncbi.nlm.nih.gov

Experiences of mobility device use over time: A multiple case study among very old Latvian women. [2015]